The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology

Biological Psychiatry

Volumn 85, Issue 6, 2019, Pages 443-453

  Belleau, Emily L ^a,b   Treadway, Michael T ^c   Pizzagalli, Diego A ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Depression; Hippocampus; Illness progression; Medial prefrontal cortex; Neuroprogression; Stress

Indexed keywords

4 AMINOBUTYRIC ACID; SEROTONIN;

BRAIN SIZE; CHRONIC STRESS; GLUTAMATERGIC SYNAPSE; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; MAJOR DEPRESSION; MEDIAL PREFRONTAL CORTEX; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REDUCTION (CHEMISTRY); REVIEW; ANIMAL; COMPLICATION; MENTAL STRESS; PATHOLOGY; PREFRONTAL CORTEX;

ANIMALS; DEPRESSIVE DISORDER, MAJOR; HIPPOCAMPUS; HUMANS; PREFRONTAL CORTEX; STRESS, PSYCHOLOGICAL;

EID: 85056863487     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2018.09.031     Document Type: Review

References (148)

1. Monroe, S.M., Harkness, K., Recurrence in major depression: A conceptual analysis. Psychol Rev 118 (2011), 655–674.
2. McKinnon, M.C., Yucel, K., Nazarov, A., MacQueen, G.M., A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci 34 (2009), 41–54.
3. Treadway, M.T., Waskom, M.L., Dillon, D.G., Holmes, A.J., Park, M.T.M., Chakravarty, M.M., et al. Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression. Biol Psychiatry 77 (2015), 285–294.
4. Videbech, P., Ravnkilde, B., Hippocampal volume and depression: A meta-analysis of MRI studies. Am J Psychiatry 161 (2004), 1957–1966.
5. Campbell, S., Marriott, M., Nahmias, C., MacQueen, G.M., Lower hippocampal volume in patients suffering from depression: A meta-analysis. Am J Psychiatry 161 (2004), 598–607.
6. Koolschijn, P.C.M.P., van Haren, N.E.M., Lensvelt-Mulders, G.J.L.M., Hulshoff Pol, H.E., Kahn, R.S., Brain volume abnormalities in major depressive disorder: A meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp 30 (2009), 3719–3735.
7. Cole, J., Costafreda, S.G., McGuffin, P., Fu, C.H.Y., Hippocampal atrophy in first episode depression: A meta-analysis of magnetic resonance imaging studies. J Affect Disord 134 (2011), 483–487.
8. Kempton, M.J., Structural neuroimaging studies in major depressive disorder. Arch Gen Psychiatry 68 (2011), 675–690.
9. Arnone, D., McIntosh, A.M., Ebmeier, K.P., Munafò, M.R., Anderson, I.M., Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses. Eur Neuropsychopharmacol 22 (2012), 1–16.
10. Bora, E., Fornito, A., Pantelis, C., Yücel, M., Gray matter abnormalities in major depressive disorder: A meta-analysis of voxel based morphometry studies. J Affect Disord 138 (2012), 9–18.
11. Du, M.Y., Wu, Q.Z., Yue, Q., Li, J., Liao, Y., Kuang, W.H., et al. Voxelwise meta-analysis of gray matter reduction in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 36 (2012), 11–16.
12. Lai, C.H., Gray matter volume in major depressive disorder: A meta-analysis of voxel-based morphometry studies. Psychiatry Res Neuroimaging 211 (2013), 37–46.
13. Arnone, D., Job, D., Selvaraj, S., Abe, O., Amico, F., Cheng, Y., et al. Computational meta-analysis of statistical parametric maps in major depression. Hum Brain Mapp 37 (2016), 1393–1404.
14. Wise, T., Radua, J., Via, E., Cardoner, N., Abe, O., Adams, T.M., et al. Common and distinct patterns of grey-matter volume alteration on major depression and bipolar disorder: Evidence from voxel-based meta-analysis. Mol Psychiatry 22 (2017), 1455–1463.
15. Han, K.-M., Won, E., Sim, Y., Tae, W.-S., Hippocampal subfield analysis in medication-naïve female patients with major depressive disorder. J Affect Disord 194 (2016), 21–29.
16. Malykhin, N.V., Carter, R., Seres, P., Coupland, N.J., Structural changes in the hippocampus in major depressive disorder: Contributions of disease and treatment. J Psychiatry Neurosci 35 (2010), 337–343.
17. Frodl, T., Jager, M., Smajstrlova, I., Born, C., Bottlender, R., Palladino, T., et al. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: A 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci 33 (2008), 423–430.
18. van Tol, M.-J., van der Wee, N.J.A., van den Heuvel, O.A., Nielen, M.M.A., Demenescu, L.R., Aleman, A., et al. Regional brain volume in depression and anxiety disorders. Arch Gen Psychiatry 67 (2010), 1002–1011.
19. MacQueen, G.M., Campbell, S., McEwen, B.S., Macdonald, K., Amano, S., Joffe, R.T., et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A 100 (2003), 1387–1392.
20. Kronmüller, K.T., Pantel, J., Köhler, S., Victor, D., Giesel, F., Magnotta, V.A., et al. Hippocampal volume and 2-year outcome in depression. Br J Psychiatry 192 (2008), 472–473.
21. Yucel, K., McKinnon, M.C., Chahal, R., Taylor, V.H., MacDonald, K., Joffe, R., et al. Anterior cingulate volumes in never-treated patients with major depressive disorder. Neuropsychopharmacology 33 (2008), 3157–3163.
22. Stratmann, M., Konrad, C., Kugel, H., Krug, A., Schoning, S., Ohrmann, P., et al. Insular and hippocampal gray matter volume reductions in patients with major depressive disorder. PLoS One, 9, 2014, e102692.
23. Wisse, L.E.M., Biessels, G.J., Stegenga, B.T., Kooistra, M., van der Veen, P.H., Zwanenburg, J.J.M., et al. Major depressive episodes over the course of 7 years and hippocampal subfield volumes at 7 Tesla MRI: The PREDICT-MR study. J Affect Disord 175 (2015), 1–7.
24. Bludau, S., Bzdok, D., Gruber, O., Kohn, N., Riedl, V., Sorg, C., et al. Medial prefrontal aberrations in major depressive disorder revealed by cytoarchitectonically informed voxel-based morphometry. Am J Psychiatry 173 (2016), 291–298.
25. Mathias, S.R., Knowles, E.E.M., Kent, J.W., McKay, D.R., Curran, J.E., de Almeida, M.A.A., et al. Recurrent major depression and right hippocampal volume: A bivariate linkage and association study. Hum Brain Mapp 37 (2016), 191–202.
26. Sheline, Y.I., Wang, P.W., Gado, M.H., Csernansky, J.G., Vannier, M.W., Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 93 (1996), 3908–3913.
27. Sheline, Y.I., Sanghavi, M., Mintun, M.A., Gado, M.H., Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19 (1999), 5034–5043.
28. Sheline, Y.I., Gado, M.H., Kraemer, H.C., Untreated depression and hippocampal volume loss. Am J Psychiatry 160 (2003), 1516–1518.
29. Serra-Blasco, M., Portella, M.J., Gómez-Ansón, B., de Diego-Adelino, X., Vives-Gilabert, Y., Puigdemont, D., et al. Effects of illness duration and treatment resistance on grey matter abnormalities in major depression. Br J Psychiatry 202 (2013), 434–440.
30. Travis, S., Coupland, N.J., Silversone, P.H., Huang, Y., Fujiwara, E., Carter, R., et al. Dentate gyrus volume and memory performance in major depressive disorder. J Affect Disord 172 (2015), 159–164.
31. Hsieh, M.H., McQuoid, D.R., Levy, R.M., Payne, M.E., MacFall, J.R., Steffens, D.C., Hippocampal volume and antidepressant response in geriatric depression. Int J Geriatr Psychiatry 17 (2002), 519–525.
32. Frodl, T., Meisenzahl, E.M., Zetzsche, T., Hohne, T., Banac, S., Schorr, C., et al. Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry 65 (2004), 492–499.
33. MacQueen, G.M., Yucel, K., Taylor, V.H., Macdonald, K., Joffe, R., Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biol Psychiatry 64 (2008), 880–883.
34. Hoogenboom, W., Perlis, R., Feasibility of studying brain morphology in major depressive disorder with structural magnetic resonance imaging and clinical data from the electronic medical record. Psychiatry Res 211 (2012), 202–213.
35. Taylor, W.D., McQuoid, D.R., Payne, M.E., Zannas, A.S., MacFall, J.R., Steffens, D.C., Hippocampus atrophy and the longitudinal course of late-life depression. Am J Geriatr Psychiatry 22 (2014), 1504–1512.
36. Phillips, J.L., Batten, L.A., Tremblay, P., Aldosary, F., Blier, P., A prospective, longitudinal study of the effect of remission on cortical thickness and hippocampal volume in patients with treatment-resistant depression. Int J Neuropsychopharmacol 18 (2015), 1–9.
37. Serra-Blasco, M., de Diego-Adeliño, J., Vives-Gilabert, Y., Trujols, J., Puigdemont, D., Carceller-Sindreu, M., et al. Naturalistic course of major depressive disorder predicted by clinical and structural neuroimaging data: A 5-year follow-up. Depress Anxiety 33 (2016), 1055–1064.
38. Frodl, T.S., Koutsouleris, N., Bottlender, R., Born, C., Jager, M., Scupin, I., et al. Depression-related variation in brain morphology over 3 years. Arch Gen Psychiatry 65 (2008), 1156–1165.
39. Chen, M.C., Hamilton, J.P., Gotlib, I.H., Decreased hippocampal volume in healthy girls at risk of depression. Arch Gen Psychiatry 67 (2010), 270–276.
40. Rao, U., Chen, L., Bidesi, A.S., Shad, M.U., Thomas, M.A., Hammen, C.L., Hippocampal changes associated with early-life adversity and vulnerability to depression. Biol Psychiatry 67 (2011), 357–364.
41. Amico, F., Meisenzahl, E., Koutsouleris, N., Reiser, M., Moller, H.J., Frodl, T., Structural MRI correlates for vulnerability and resilience to major depressive disorder. J Psychiatry Neurosci 36 (2011), 15–22.
42. Carballedo, A., Lisiecka, D., Fagan, A., Saleh, K., Ferguson, Y., Connolly, G., et al. Early life adversity is associated with brain changes in subjects at family risk for depression. World J Biol Psychiatry 13 (2012), 569–578.
43. Holmes, A.J., Lee, P.H., Hollinshead, M.O., Bakst, L., Roffman, J.L., Smoller, J.W., et al. Individual differences in amygdala-medial prefrontal anatomy link negative affect, impaired social functioning, and polygenic depression risk. J Neurosci 32 (2012), 18087–18100.
44. Little, K., Olsson, C.A., Whittle, S., Youssef, G.J., Byrne, M.L., Simmons, J.G., et al. Association between serotonin transporter genotype, brain structure and adolescent-onset major depressive disorder: A longitudinal prospective study. Transl Psychiatry, 4, 2014, e445.
45. Little, K., Olsson, C.A., Youssef, G.J., Whittle, S., Simmons, J.G., Yucel, M., et al. Linking the serotonin transporter gene, family environments, hippocampal volume and depression onset: A prospective imaging gene × environment analysis. J Abnorm Psychol 124 (2015), 834–849.
46. Jayatissa, M.N., Hennigsen, K., Nikolajsen, G., West, M.J., Wiborg, O., A reduced number of hippocampal granule cells does not associate with an anhedonia-like phenotype in a rat chronic mild stress model of depression. Stress 13 (2010), 95–105.
47. Delgado y Palacios, R., Campo, A., Henningsen, K., Verhoye, M., Poot, D., Dijkstra, J., et al. Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model. Biol Psychiatry 70 (2011), 449–457.
48. Papagni, S.A., Benetti, S., Arulanantham, S., Mccrory, E., McGuire, P., Mechelli, A., Effects of stressful life events on human brain structure: A longitudinal voxel-based morphometry study. Stress 14 (2011), 227–232.
49. Kanzari, A., Bourier-Lucas, C., Freyssin, A., Abrous, D.N., Haddjeri, N., Lucas, G., Inducing a long-term potentiation in the dentate gyrus is sufficient to produce rapid antidepressant effects. Mol Psychiatry 23 (2018), 587–596.
50. Monroe, S.M., Harkness, K.L., Life stress, the “kindling” hypothesis, and the recurrence of depression: Considerations from a life stress perspective. Psychol Rev 112 (2005), 417–445.
51. Ormel, J., Oldehinkel, A.J., Brilman, E.I., The interplay of neuroticism, difficulties, and life events in the etiology of major and subsyndromal, first and recurrent depressive episodes in later life. Am J Psychiatry 158 (2001), 885–891.
52. Stroud, C.B., Davila, J., Hammen, C., Vrshek-Schallhorn, S., Severe and nonsevere events in first onsets versus recurrences of depression: Evidence for stress sensitization. J Abnorm Psychol 120 (2011), 142–154.
53. Kronmüller, K.T., Pantel, J., Götz, B., Kohler, S., Victor, D., Mudt, C., et al. Life events and hippocampal volume in first-episode major depression. J Affect Disord 110 (2008), 241–247.
54. Hammen, C., Henry, R., Daley, S.E., Depression and sensitization to stressors among young women as a function of childhood adversity. J Consult Clin Psychol 68 (2000), 782–787.
55. Oldehinkel, A.J., Ormel, J., Verhulst, F.C., Nederhof, E., Childhood adversities and adolescent depression: A matter of both risk and resilience. Dev Psychopathol 26 (2014), 1067–1075.
56. Nanni, V., Uher, R., Danese, A., Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: A meta-analysis. Am J Psychiatry 169 (2012), 141–151.
57. Vythilingham, M., Heim, C., Newport, J., Miller, A.H., Anderson, E., Bronen, R., et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry 159 (2002), 2072–2080.
58. Treadway, M.T., Grant, M.M., Ding, Z., Hollon, S.D., Gore, J.C., Shelton, R.C., Early adverse events, HPA activity and rostral anterior cingulate volume in MDD. PLoS One, 4, 2009, e4887.
59. Frodl, T., Reinhold, E., Koutsouleris, N., Donohoe, G., Bondy, B., Reiser, M., et al. Childhood stress, serotonin transporter gene and brain structures in major depression. Neuropsychopharmacology 35 (2010), 1383–1390.
60. Frodl, T., Reinhold, E., Koutsouleris, N., Reiser, M., Meisenzahl, E.M., Interaction of childhood stress with hippocampus and prefrontal cortex volume reduction in major depression. J Psychiatr Res 44 (2010), 799–807.
61. Opel, N., Redlich, R., Zwanzger, P., Grotegerd, D., Arolt, V., Heindel, W., et al. Hippocampal atrophy in major depression: A function of childhood maltreatment rather than diagnosis. Neuropsychopharmacology 39 (2014), 2723–2731.
62. Gerritsen, L., Van Velzen, L., Schmaal, L., van der Graaf, Y., van der Wee, N., van Tol, M.-J., et al. Childhood maltreatment modifies the relationship of depression with hippocampal volume. Psychol Med 45 (2015), 3517–3526.
63. Colle, R., Segawa, T., Chupin, M., Tran, Dong, MNT, Hardy, P., Falissard, B., et al. Early life adversity is associated with a smaller hippocampus in male but not female depressed in-patients: A case-control study. BMC Psychiatry, 17, 2017, 71.
64. Chaney, A., Carballedo, A., Amico, F., Fagan, A., Skokauskas, N., Meaney, J., et al. Effect of childhood maltreatment on brain structure in adult patients with major depressive disorder and healthy participants. J Psychiatry Neurosci 39 (2014), 50–59.
65. Teicher, M.H., Anderson, C.M., Polcari, A., Childhood maltreatment is associated with reduced volume in the hippocampal subfields CA3, dentate gyrus, and subiculum. Proc Natl Acad Sci U S A 109 (2012), E563–E572.
66. Heim, C., Newport, D.J., Heit, S., Graham, Y.P., Wilcox, M., Bonsall, R., et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 284 (2000), 592–597.
67. Gouin, J.P., Glaser, R., Malarkey, W.B., Beversdorf, D., Kiecolt-Glaser, J.K., Childhood abuse and inflammatory responses to daily stressors. Ann Behav Med 44 (2012), 287–292.
68. Moylan, S., Maes, M., Wray, N.R., Berk, M., The neuroprogressive nature of major depressive disorder: Pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 18 (2013), 595–606.
69. Saaltink, D.J., Vreugdenhil, E., Stress, glucocorticoid receptors, and adult neurogenesis: A balance between excitation and inhibition?. Cell Mol Life Sci 71 (2014), 2499–2515.
70. Willner, P., Scheel-Krüger, J., Belzung, C., The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev 37 (2013), 2331–2371.
71. Stetler, C., Miller, G.E., Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosom Med 73 (2011), 114–126.
72. Bockting, C.L.H., Lok, A., Visser, I., Assies, J., Koeter, M.W., Schene, A.H., Lower cortisol levels predict recurrence in remitted patients with recurrent depression: A 5.5 year prospective study. Psychiatry Res 200 (2012), 281–287.
73. Lok, A., Mocking, RJT, Ruhé, H.G., Visser, I., Koeter, M.W.J., Assies, J., et al. Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression. Psychoneuroendocrinology 37 (2012), 892–902.
74. Vreeburg, S.A., Hoogendijk, W.J.G., DeRijk, R.H., van Dyck, R., Smit, J.H., Zitman, F.G., et al. Salivary cortisol levels and the 2-year course of depressive and anxiety disorders. Psychoneuroendocrinology 38 (2013), 1494–1502.
75. Zorn, J.V., Schür, R.R., Boks, M.P., Kahn, R.S., Joëls, M., Vinkers, C.H., Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology 77 (2017), 25–36.
76. Morris, M.C., Rao, U., Cortisol response to psychosocial stress during a depressive episode and remission. Stress 17 (2014), 51–58.
77. Raison, C.L., Miller, A.H., When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 160 (2003), 1554–1565.
78. McKay, M.S., Zakzanis, K.K., The impact of treatment on HPA axis activity in unipolar major depression. J Psychiatr Res 44 (2010), 183–192.
79. Travis, S.G., Coupland, N.J., Hegadoren, K., Silverstone, P.H., Huang, Y., Carter, R., et al. Effects of cortisol on hippocampal subfields volumes and memory performance in healthy control subjects and patients with major depressive disorder. J Affect Disord 201 (2016), 34–41.
80. Jin, R.O., Mason, S., Mellon, S.H., Epel, E.S., Reus, V.I., Mahan, L., et al. Cortisol/DHEA ratio and hippocampal volume: A pilot study in major depression and healthy controls. Psychoneuroendocrinology 72 (2016), 139–146.
81. Maninger, N., Wolkowitz, O.M., Reus, V.I., Epel, E.S., Mellon, S.H., Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 30 (2009), 65–91.
82. Kaymak, S.U., Demir, B., Şentürk, S., Tatar, I., Aldur, M.M., Uluǧ, B., Hippocampus, glucocorticoids and neurocognitive functions in patients with first-episode major depressive disorders. Eur Arch Psychiatry Clin Neurosci 260 (2010), 217–223.
83. O'Brien, J.T., Lloyd, A., McKeith, I., Gholkar, A., Ferrier, N., A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 161 (2004), 2081–2090.
84. Vythilingam, M., Vermetten, E., Anderson, G.M., Luckenbaugh, D., Anderson, E.R., Snow, J., et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: Effects of treatment. Biol Psychiatry 56 (2004), 101–112.
85. Colla, M., Kronenberg, G., Deuschle, M., Meichel, K., Hagen, T., Bohrer, M., et al. Hippocampal volume reduction and HPA-system activity in major depression. J Psychiatr Res 41 (2007), 553–560.
86. Gerritsen, L., Comijs, H.C., van der Graaf, Y., Knoops, A.J.G., Penninx, B.W.J.H., Geerlings, M.I., Depression, hypothalamic pituitary adrenal axis, and hippocampal and entorhinal cortex volumes—the SMART Medea study. Biol Psychiatry 70 (2011), 373–380.
87. Schuhmacher, A., Mössner, R., Jessen, F., Scheef, L., Block, W., Belloche, A.C., et al. Association of amygdala volumes with cortisol secretion in unipolar depressed patients. Psychiatry Res 202 (2012), 96–103.
88. Slavich, G.M., Irwin, M.R., From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychol Bull 140 (2014), 774–815.
89. Iwata, M., Ota, K.T., Li, X.Y., Sakaue, F., Li, N., Dutheil, S., et al. Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor. Biol Psychiatry 80 (2016), 12–22.
90. Couch, Y., Anthony, D.C., Dolgov, O., Revischin, A., Festoff, B., Santos, A.I., et al. Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia. Brain Behav Immun 29 (2013), 136–146.
91. Pan, Y., Chen, X.Y., Zhang, Q.Y., Kong, L.D., Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats. Brain Behav Immun 41 (2014), 90–100.
92. Chesnokova, V., Pechnick, R.N., Wawrowsky, K., Chronic peripheral inflammation, hippocampal neurogenesis, and behavior. Brain Behav Immun 58 (2016), 1–8.
93. Setiawan, E., Wilson, A.A., Mizrahi, R., Rusjan, P.M., Miler, L., Rajkowska, G., et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72 (2015), 268–275.
94. Holmes, S.E., Hinz, R., Conen, S., Gregory, C.J., Matthews, J.C., Anton-Rodriguez, J.M., et al. Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: A positron emission tomography study. Biol Psychiatry 83 (2018), 61–69.
95. Frodl, T., Carballedo, A., Hughes, M.M., Saleh, K., Fagan, A., Skokauskas, N., et al. Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: High IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Transl Psychiatry 2 (2012), 1–8.
96. van Velzen, L.S., Schmaal, L., Milaneschi, Y., van Tol, M.J., van der Wee, N.J.A., Veltman, D.J., et al. Immunometabolic dysregulation is associated with reduced cortical thickness of the anterior cingulate cortex. Brain Behav Immun 60 (2017), 361–368.
97. Savitz, J., Frank, M.B., Victor, T., Bebak, M., Bellgowan, P.S., McKinney, B.A., et al. Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities. Brain Behav Immun 31 (2013), 161–171.
98. Sowa-Kućma, M., Styczeń, K., Siwek, M., Misztak, P., Nowak, R.J., Dudek, D., et al. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts. Prog Neuropsychopharmacol Biol Psychiatry 81 (2018), 372–383.
99. Dunjic-Kostic, B., Ivkovic, M., Radonjic, N.V., Petronijevic, N.D., Pantovic, M., Damjanovic, A., et al. Melancholic and atypical major depression—Connection between cytokines, psychopathology and treatment. Prog Neuropsychopharmacol Biol Psychiatry 43 (2013), 1–6.
100. Eller, T., Vasar, V., Shlik, J., Maron, E., Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008), 445–450.
101. Lindqvist, D., Dhabhar, F.S., James, S.J., Hough, C.M., Jain, F.A., Bersani, F.S., et al. Oxidative stress, inflammation and treatment response in major depression. Psychoneuroendocrinology 76 (2017), 197–205.
102. Filipović, D., Todorović, N., Bernardi, R.E., Gass, P., Oxidative and nitrosative stress pathways in the brain of socially isolated adult male rats demonstrating depressive- and anxiety-like symptoms. Brain Struct Funct 222 (2017), 1–20.
103. Che, Y., Wang, J.F., Shao, L., Young, L.T., Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J Psychiatry Neurosci 5 (2010), 296–302.
104. Meyer, J.H., Wilson, A.A., Sagrati, S., Miler, L., Rusjan, P., Bloomfield, P.M., et al. Brain monoamine oxidase A binding in major depressive disorder. Arch Gen Psychiatry 66 (2009), 1304–1312.
105. Michel, T.M., Frangou, S., Thiemeyer, D., Camara, S., Jecel, J., Nara, K., et al. Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder—A postmortem study. Psychiatry Res 151 (2007), 145–150.
106. Gawryluk, J.W., Wang, J.F., Andreazza, A.C., Shao, L., Young, L.T., Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 14 (2011), 123–130.
107. Lindqvist, D., Mueller, S., Mellon, S.H., Su, Y., Epel, E.S., Reus, V.I., et al. Peripheral antioxidant markers are associated with total hippocampal and CA3/dentate gyrus volume in MDD and healthy controls—Preliminary findings. Psychiatry Res 224 (2014), 168–174.
108. Baek, S.-E., Lee, G.-J., Rhee, C.-K., Rho, D.-Y., Kim, D.-H., Huh, S., et al. Decreased total antioxidant activity in major depressive disorder patients non-responsive to antidepressant treatment. Psychiatry Investig 13 (2016), 222–226.
109. Śliwiński, T., Elevated level of DNA damage and impaired repair of oxidative DNA damage in patients with recurrent depressive disorder. Med Sci Monit 21 (2015), 412–418.
110. Czarny, P., Kwiatkowski, D., Toma, M., Kubiak, J., Silwinska, A., Talarowska, M., et al. Impact of single nucleotide polymorphisms of base excision repair genes on DNA damage and efficiency of DNA repair in recurrent depression disorder. Mol Neurobiol 54 (2017), 4150–4159.
111. Jorgensen, A., Krogh, J., Miskowiak, K., Bolwig, T.G., Kessing, L.V., Fink-Jensen, A., et al. Systemic oxidatively generated DNA/RNA damage in clinical depression: Associations to symptom severity and response to electroconvulsive therapy. J Affect Disord 149 (2013), 355–362.
112. Stefanescu, C., Ciobica, A., The relevance of oxidative stress status in first episode and recurrent depression. J Affect Disord 143 (2012), 34–38.
113. Talarowska, M., Orzechowska, A., Szemraj, J., Su, K.-P., Maes, M., Gałecki, P., Manganese superoxide dismutase gene expression and cognitive functions in recurrent depressive disorder. Neuropsychobiology 70 (2014), 23–28.
114. Bekris, S., Antoniou, K., Daskas, S., Papadopoulou-Daifoti, Z., Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behav Brain Res 161 (2005), 45–59.
115. Luo, D.D., An, S.C., Zhang, X., Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress. Brain Res Bull 77 (2008), 8–12.
116. Harro, J., Tõnissaar, M., Eller, M., Kask, A., Oreland, L., Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: Effects on behavior and monoamine neurochemistry. Brain Res 899 (2001), 227–239.
117. López-Figueroa, A.L., Norton, C.S., López-Figueroa, M.O., Armellini-Dodel, D., Burke, S., Akil, H., et al. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol Psychiatry 55 (2004), 225–233.
118. Gryglewski, G., Lanzenberger, R., Kranz, G.S., Cumming, P., Meta-analysis of molecular imaging of serotonin transporters in major depression. J Cereb Blood Flow Metab 34 (2014), 1096–1103.
119. Kambeitz, J.P., Howes, O.D., The serotonin transporter in depression: Meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression. J Affect Disord 186 (2015), 358–366.
120. Maes, M., Ringel, K., Kubera, M., Berk, M., Rybakowski, J., Increased autoimmune activity against 5-HT: A key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J Affect Disord 136 (2012), 386–392.
121. Grimm, S., Luborzewski, A., Schubert, F., Merkyl, A., Kronenberg, G., Colla, M., et al. Region-specific glutamate changes in patients with unipolar depression. J Psychiatr Res 46 (2012), 1059–1065.
122. Sun, H., Su, R., Zhang, X., Wen, J., Yao, D., Gao, X., et al. Hippocampal GR- and CB1-mediated mGluR5 differentially produces susceptibility and resilience to acute and chronic mild stress in rats. Neuroscience 357 (2017), 295–302.
123. De Vasconcellos-Bittencourt, A.P.S., Vendite, D.A., Nassif, M., Crema, L.M., Frozza, R., Thomazi, A.P., et al. Chronic stress and lithium treatments alter hippocampal glutamate uptake and release in the rat and potentiate necrotic cellular death after oxygen and glucose deprivation. Neurochem Res 36 (2011), 793–800.
124. Jett, J.D., Bulin, S.E., Hatherall, L.C., McCartney, C.M., Morilak, D.A., Deficits in cognitive flexibility induced by chronic unpredictable stress are associated with impaired glutamate neurotransmission in the rat medial prefrontal cortex. Neuroscience 346 (2017), 284–297.
125. Yuen, E.Y., Wei, J., Liu, W., Zhong, P., Li, X., Yan, Z., Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex. Neuron 73 (2012), 962–977.
126. John, C.S., Smith, K.L., Van't Veer, A., Gompf, H.S., Carlezon, W.A., Cohen, B.M., et al. Blockade of astrocytic glutamate uptake in the prefrontal cortex induces anhedonia. Neuropsychopharmacology 37 (2012), 2467–2475.
127. de Diego-Adeliño, J., Portella, M.J., Gómez-Ansón, B., Lopez-Moruelo, O., Serra-Blasco, M., Yolanda, V., et al. Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden. J Psychiatry Neurosci 38 (2013), 107–116.
128. Portella, M.J., de Diego-Adeliño, J., Gómez-Ansón, B., Morgan-Ferrando, R., Vives, Y., Puigdemont, D., et al. Ventromedial prefrontal spectroscopic abnormalities over the course of depression: A comparison among first episode, remitted recurrent and chronic patients. J Psychiatr Res 45 (2011), 427–434.
129. Croarkin, P.E., Nakonezny, P.A., Husain, M.M., Melton, T., Buyukdura, J.S., Kennard, B.D., et al. Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder. JAMA Psychiatry 70 (2013), 291–299.
130. Cavus, I., Pan, J.W., Hetherington, H.P., Walid, A.-S., Hitten, P.S., Vives, K.P., et al. Decreased hippocampal volume on MRI is associated with increased extracellular glutamate in epilepsy patients. Epilepsia 49 (2008), 1358–1366.
131. Lee, Y., Son, H., Kim, G., Kim, S., Lee, D.H., Roh, G.S., et al. Glutamate deficiency in the prefrontal cortex increases depressive-like behaviors in male mice. J Psychiatry Neurosci 38 (2013), 183–191.
132. Chowdry, G.M., Zhang, J., Thomas, M., Banas, M., Ma, X., Pittman, B., et al. Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant effects. Mol Psychiatry 22 (2017), 120–126.
133. Sancora, G., Banasr, M., From pathophysiology to novel antidepressant drugs: Glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry 73 (2013), 1172–1179.
134. Luscher, B., Shen, Q., Sahir, N., The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 16 (2011), 383–406.
135. Hemanth Kumar, B.S., Mishra, S.K., Rana, P., Singh, S., Khushu, S., Neurodegenerative evidences during early onset of depression in CMS rats as detected by proton magnetic resonance spectroscopy at 7T. Behav Brain Res 232 (2012), 53–59.
136. Ma, K., Xu, A., Cui, S., Sun, M.R., Xue, Y.C., Wang, J.H., Impaired GABA synthesis, uptake and release are associated with depression-like behaviors induced by chronic mild stress. Transl Psychiatry, 6, 2016, e910.
137. A receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons. J Neurosci 21 (2001), 6502–6511.
138. Rubio-Casillas, A., Fernández-Guasti, A., The dose makes the poison: From glutamate-mediated neurogenesis to neuronal atrophy and depression. Rev Neurosci 27 (2016), 599–622.
139. Abdallah, C.G., Jackowski, A., Sato, J.R., Mao, X., Kang, G., Cheema, R., et al. Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder. Eur Neuropsychopharmacol 25 (2015), 1082–1090.
140. Gabbay, V., Mao, X., Klein, R.G., Ely, B.A., Babb, J.S., Panzer, A.M., et al. Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: Relationship to anhedonia. Arch Gen Psychiatry 69 (2012), 139–149.
141. Hasler, G., van der Veen, J.W., Tumonis, T., Meyers, N., Shen, J., Drevets, W.C., Reduced prefrontal glutamate/glutamine and γ-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64 (2007), 193–200.
142. Levinson, A.J., Fitzgerald, P.B., Favalli, G., Blumberger, D.M., Daigle, M., Daskalakis, Z.J., Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry 67 (2010), 458–464.
143. Price, R.B., Shungu, D.C., Mao, X., Nestadt, P., Kelly, C., Collins, K.A., et al. Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: Relationship to treatment resistance in major depressive disorder. Biol Psychiatry 65 (2009), 792–800.
144. Capuron, L., Miller, A.H., Immune system to brain signaling: Neuropsychopharmacological implications. Pharmacol Ther 130 (2011), 226–238.
145. Lugo-Huitron, R., Muniz, P.U., Pineda, P., Pedrazza-Chaverri, J., Rios, C., Perex-de la Cruz, V., Quinolinic acid: An endogenous neurotoxin with multiple targets. Oxid Med Cell Longev, 2013, 2013, 104024.
146. Savitz, J., Drevets, W.C., Smith, C.M., Victor, T.A., Wurfel, B.E., Bellgowen, P.S.F., et al. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology 40 (2015), 463–471.
147. Meier, T.B., Drevets, W.C., Wurfel, B.E., Ford, B.N., Morris, H.M., Victor, T.A., et al. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder. Brain Behav Immun 53 (2016), 39–48.
148. Parrott, J.M., Redus, L., Santana-Coelho, D., Morales, J., Gao, X., O'Connor, J.C., Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation. Transl Psychiatry, 6, 2016, e918.